Numax Uses, Dosage, Side Effects and more
| Trade Name | Numax |
| Generic | Motavizumab |
| Motavizumab Other Names | Motavizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in viral infection and pediatric indications.
How Numax works
Numax is a second generation, ultra-potent, affinity-matured, humanized mAb derived from palivizumab that reduces replication of Respiratory Syncytial Virus (RSV), a pathogen which causes lower respiratory tract disease.
